Last $1.18 USD
Change Today 0.00 / 0.00%
Volume 0.0
IFIT On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/15/14 All times are local (Market data is delayed by at least 15 minutes).

isatori inc (IFIT) Snapshot

Open
$1.39
Previous Close
$1.18
Day High
$1.39
Day Low
$1.18
52 Week High
09/30/13 - $3.27
52 Week Low
09/8/14 - $1.14
Market Cap
15.2M
Average Volume 10 Days
2.5K
EPS TTM
$-0.02
Shares Outstanding
12.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ISATORI INC (IFIT)

Related News

No related news articles were found.

isatori inc (IFIT) Related Businessweek News

No Related Businessweek News Found

isatori inc (IFIT) Details

iSatori, Inc., a consumer products company, is engaged in the research, design, development, manufacture, marketing, sale, and distribution of various nutritional and dietary supplement products worldwide. It offers sports nutritionals; energy and sports drinks and shots; meal replacement proteins, protein-based products related to weight loss, and nutritional bars; and weight loss products. The company sells its products through online marketing, Fortune 500 retailers, and retail stores. iSatori, Inc. was founded in 2001 and is headquartered in Golden, Colorado.

23 Employees
Last Reported Date: 08/11/14
Founded in 2001

isatori inc (IFIT) Top Compensated Officers

Founder, Owner, Chairman, Chief Executive Off...
Total Annual Compensation: $225.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $126.0K
Compensation as of Fiscal Year 2013.

isatori inc (IFIT) Key Developments

iSatori, Inc. Launches Sinetrim(TM), Weight-Loss Pill

iSatori, Inc. announced the launch of their newest weight-loss innovation, called Sinetrim(TM), featuring patented Sinetrol. iSatori expects Sinetrim to be well received by distributors, retailers, and consumers alike, especially due to the robust scientific support for the patented Sinetrol(R) ingredient. Sinetrim(TM) is the first to launch Sinetrol(R) as a patented synergistic blend of polyphenolic compounds derived from Mediterranean citrus fruits. iSatori began shipping Sinetrim(TM) to retailers in August 2014, and the product is now available nationwide at GNC stores. Sinetrim(TM) with patented Sinetrol(R) is also exclusively available through Europa Sports.

Isatori, Inc. Secures Expanded Bank Line of Credit Through Renewed Colorado Business Bank Relationship

iSatori Inc. announced that Colorado Business Bank of Denver has renewed and expanded its commercial bank line of credit availability for iSatori from $1.5 million to $2 million, based on the company's operating performance and assets. This extended borrowing relationship is under the same terms, conditions, similar borrowing base covenants of the prior revolving line of credit, and it has been renewed for another 15 months, through November 2015. This additional borrowing capacity will allow the Company to support the growth of its new category-defining sports nutrition products, like Bio-Gro(TM), as well as continue to build up inventory to support their popular energy pill, Energize, in food, drug, and mass merchandisers throughout the United States.

iSatori, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

iSatori, Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company has posted total revenue of $2,918,367 against $2,279,928 a year ago. Income from operations was $213,951 against $36,397 a year ago. Income before income tax was $399,481 against loss before income tax of $61,126 a year ago. Net income was $336,099 or $0.02 diluted per share against $133,222 or $0.01 diluted per share a year ago. For the six months, the company has posted $6,179,634 against $4,536,295 a year ago. Income from operations was $568,212 against loss from operations of $44,317 a year ago. Income before income tax was $672,337 against loss before income tax of $314,112 a year ago. Net income was $336,099 or $0.05 diluted per share against $129,898 or $0.01 diluted per share a year ago. Cash flow provided by operations was a positive $825,829 for the six months ended June 30, 2014, compared to cash used of $163,475 for the six months ended June 30, 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IFIT:US $1.18 USD 0.00

IFIT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $42.90 USD +0.18
USANA Health Sciences Inc $72.07 USD +1.27
Vitamin Shoppe Inc $43.23 USD +0.45
View Industry Companies
 

Industry Analysis

IFIT

Industry Average

Valuation IFIT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.2x
Price/Book 4.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISATORI INC, please visit www.isatori.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.